Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Annals of Hematology
|
January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
M R Weihrauch, D Re, S Bischoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18
C-A Voltin, H Goergen, C Baues, et al.
Nuklearmedizin. Nuclear Medicine
|
September 22, 2015
Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma
C Kobe, G Kuhnert, H Haverkamp, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 6, 2013
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib
M Bos, M Gardizi, H U Schildhaus, et al.
Nuklearmedizin. Nuclear Medicine
|
January 10, 2006
Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice
M Biermann, M K Pixberg, U Dörr, et al.
Der Urologe. Ausg. A
|
April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]
H Ahmadzadehfar, P Albers, A Bockisch, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Annals of Hematology
|
January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
M R Weihrauch, D Re, S Bischoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18
C-A Voltin, H Goergen, C Baues, et al.
Nuklearmedizin. Nuclear Medicine
|
September 22, 2015
Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma
C Kobe, G Kuhnert, H Haverkamp, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 6, 2013
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib
M Bos, M Gardizi, H U Schildhaus, et al.
Nuklearmedizin. Nuclear Medicine
|
January 10, 2006
Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice
M Biermann, M K Pixberg, U Dörr, et al.
Der Urologe. Ausg. A
|
April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]
H Ahmadzadehfar, P Albers, A Bockisch, et al.
Page
of 13